CPHRF
Price
$11.48
Change
+$0.03 (+0.26%)
Updated
Sep 4 closing price
Capitalization
291.59M
62 days until earnings call
CURLF
Price
$2.80
Change
+$0.06 (+2.19%)
Updated
Sep 4 closing price
Capitalization
2.15B
66 days until earnings call
Interact to see
Advertisement

CPHRF vs CURLF

Header iconCPHRF vs CURLF Comparison
Open Charts CPHRF vs CURLFBanner chart's image
Cipher Pharmaceuticals
Price$11.48
Change+$0.03 (+0.26%)
Volume$17.8K
Capitalization291.59M
Curaleaf
Price$2.80
Change+$0.06 (+2.19%)
Volume$436.82K
Capitalization2.15B
CPHRF vs CURLF Comparison Chart in %
Loading...
CPHRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CURLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CPHRF vs. CURLF commentary
Sep 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CPHRF is a Buy and CURLF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 05, 2025
Stock price -- (CPHRF: $11.48 vs. CURLF: $2.80)
Brand notoriety: CPHRF and CURLF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CPHRF: 84% vs. CURLF: 36%
Market capitalization -- CPHRF: $291.59M vs. CURLF: $2.15B
CPHRF [@Pharmaceuticals: Generic] is valued at $291.59M. CURLF’s [@Pharmaceuticals: Generic] market capitalization is $2.15B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.9B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CPHRF’s FA Score shows that 2 FA rating(s) are green whileCURLF’s FA Score has 0 green FA rating(s).

  • CPHRF’s FA Score: 2 green, 3 red.
  • CURLF’s FA Score: 0 green, 5 red.
According to our system of comparison, CPHRF is a better buy in the long-term than CURLF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CPHRF’s TA Score shows that 7 TA indicator(s) are bullish while CURLF’s TA Score has 2 bullish TA indicator(s).

  • CPHRF’s TA Score: 7 bullish, 4 bearish.
  • CURLF’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, CPHRF is a better buy in the short-term than CURLF.

Price Growth

CPHRF (@Pharmaceuticals: Generic) experienced а +0.37% price change this week, while CURLF (@Pharmaceuticals: Generic) price change was -16.91% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.80%. For the same industry, the average monthly price growth was +10.24%, and the average quarterly price growth was +86.08%.

Reported Earning Dates

CPHRF is expected to report earnings on Nov 06, 2025.

CURLF is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (-0.80% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CURLF($2.15B) has a higher market cap than CPHRF($292M). CURLF YTD gains are higher at: 79.487 vs. CPHRF (15.192). CURLF has higher annual earnings (EBITDA): 220M vs. CPHRF (16.7M). CURLF has more cash in the bank: 102M vs. CPHRF (11.3M). CPHRF has less debt than CURLF: CPHRF (25.5M) vs CURLF (843M). CURLF has higher revenues than CPHRF: CURLF (1.29B) vs CPHRF (47.6M).
CPHRFCURLFCPHRF / CURLF
Capitalization292M2.15B14%
EBITDA16.7M220M8%
Gain YTD15.19279.48719%
P/E Ratio24.96N/A-
Revenue47.6M1.29B4%
Total Cash11.3M102M11%
Total Debt25.5M843M3%
FUNDAMENTALS RATINGS
CPHRF vs CURLF: Fundamental Ratings
CPHRF
CURLF
OUTLOOK RATING
1..100
318
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
49
Fair valued
PROFIT vs RISK RATING
1..100
29100
SMR RATING
1..100
6196
PRICE GROWTH RATING
1..100
4034
P/E GROWTH RATING
1..100
12100
SEASONALITY SCORE
1..100
n/a6

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CURLF's Valuation (49) in the null industry is in the same range as CPHRF (64). This means that CURLF’s stock grew similarly to CPHRF’s over the last 12 months.

CPHRF's Profit vs Risk Rating (29) in the null industry is significantly better than the same rating for CURLF (100). This means that CPHRF’s stock grew significantly faster than CURLF’s over the last 12 months.

CPHRF's SMR Rating (61) in the null industry is somewhat better than the same rating for CURLF (96). This means that CPHRF’s stock grew somewhat faster than CURLF’s over the last 12 months.

CURLF's Price Growth Rating (34) in the null industry is in the same range as CPHRF (40). This means that CURLF’s stock grew similarly to CPHRF’s over the last 12 months.

CPHRF's P/E Growth Rating (12) in the null industry is significantly better than the same rating for CURLF (100). This means that CPHRF’s stock grew significantly faster than CURLF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CPHRFCURLF
RSI
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
72%
Bearish Trend 2 days ago
86%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 9 days ago
80%
Declines
ODDS (%)
Bearish Trend 22 days ago
80%
Bearish Trend 3 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
87%
Aroon
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
CPHRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CURLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ARGFX78.10N/A
N/A
Ariel Fund Investor
PMPSX97.75N/A
N/A
ProFunds Precious Metals UltraSector Svc
MRSAX25.66N/A
N/A
MFS Research International A
PIIRX16.33N/A
N/A
Putnam International Value R
RDLAX11.83N/A
N/A
Columbia Disciplined Growth A

CPHRF and

Correlation & Price change

A.I.dvisor tells us that CPHRF and OGI have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CPHRF and OGI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CPHRF
1D Price
Change %
CPHRF100%
+0.26%
OGI - CPHRF
23%
Poorly correlated
-0.62%
SDZNY - CPHRF
21%
Poorly correlated
-1.30%
CBWTF - CPHRF
8%
Poorly correlated
-2.73%
CANQF - CPHRF
6%
Poorly correlated
N/A
CURLF - CPHRF
5%
Poorly correlated
+2.19%
More

CURLF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CURLF has been closely correlated with GTBIF. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if CURLF jumps, then GTBIF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CURLF
1D Price
Change %
CURLF100%
+2.19%
GTBIF - CURLF
82%
Closely correlated
-2.94%
TCNNF - CURLF
80%
Closely correlated
-3.33%
VRNOF - CURLF
78%
Closely correlated
+0.79%
CRLBF - CURLF
76%
Closely correlated
-3.39%
TSNDF - CURLF
75%
Closely correlated
-9.57%
More